PAUL COLVIN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PAUL COLVIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PAUL COLVIN. PAUL COLVIN is EVP--Clinical Development in PHARMACEUTICAL PRODUCT DEVELOPMENT INC ($PPDI) and Pres., Clinical Solutions in Syneos Health, Inc. ($INCR).
Latest Insider Trading Transactions of PAUL COLVIN
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 04 2021 | INCR | Syneos Health, Inc ... | COLVIN PAUL | Pres., Clinical Sol ... | Grant | A | 0.00 | 1,048 | 0 | 30,952 | 29.9 K to 31 K (+3.50 %) |
Mar 04 2021 | INCR | Syneos Health, Inc ... | COLVIN PAUL | Pres., Clinical Sol ... | Grant | A | 0.00 | 1,629 | 0 | 29,904 | 28.3 K to 29.9 K (+5.76 %) |
Feb 03 2021 | INCR | Syneos Health, Inc ... | COLVIN PAUL | Pres., Clinical Sol ... | Sell | S | 74.82 | 8,486 | 634,923 | 28,275 | 36.8 K to 28.3 K (-23.08 %) |
Jan 20 2021 | INCR | Syneos Health, Inc ... | COLVIN PAUL | Pres., Clinical Sol ... | Grant | A | 0.00 | 11,463 | 0 | 36,761 | 25.3 K to 36.8 K (+45.31 %) |
Jan 20 2021 | INCR | Syneos Health, Inc ... | COLVIN PAUL | Pres., Clinical Sol ... | Payment of Exercise | F | 75.42 | 1,768 | 133,343 | 25,298 | 27.1 K to 25.3 K (-6.53 %) |
Jan 11 2021 | INCR | Syneos Health, Inc ... | COLVIN PAUL | Pres., Clinical Sol ... | Payment of Exercise | F | 73.59 | 2,031 | 149,461 | 27,066 | 29.1 K to 27.1 K (-6.98 %) |
Apr 15 2020 | INCR | Syneos Health, Inc ... | COLVIN PAUL | Pres., Clinical Sol ... | Grant | A | 0.00 | 2,491 | 0 | 29,346 | 26.9 K to 29.3 K (+9.28 %) |
Mar 23 2020 | INCR | Syneos Health, Inc ... | COLVIN PAUL | Pres., Clinical Sol ... | Buy | P | 36.65 | 1,300 | 47,645 | 26,855 | 25.6 K to 26.9 K (+5.09 %) |
Jan 17 2020 | INCR | Syneos Health, Inc ... | COLVIN PAUL | Pres., Clinical Sol ... | Grant | A | 0.00 | 11,862 | 0 | 25,555 | 13.7 K to 25.6 K (+86.63 %) |
Jan 09 2020 | INCR | Syneos Health, Inc ... | COLVIN PAUL | Pres., Clinical Sol ... | Payment of Exercise | F | 59.96 | 1,404 | 84,184 | 13,693 | 15.1 K to 13.7 K (-9.30 %) |
Jan 03 2020 | INCR | Syneos Health, Inc ... | COLVIN PAUL | Pres., Clinical Sol ... | Payment of Exercise | F | 59.51 | 249 | 14,818 | 15,097 | 15.3 K to 15.1 K (-1.62 %) |
Dec 06 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Option Exercise | D | 0.00 | 10,000 | 0 | 0 | |
Dec 06 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Option Exercise | D | 37.51 | 31,052 | 1,164,761 | 0 | |
Dec 06 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Option Exercise | D | 43.26 | 15,526 | 671,655 | 0 | |
Dec 06 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Option Exercise | D | 37.69 | 11,386 | 429,138 | 0 | |
Dec 06 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Option Exercise | D | 25.74 | 15,992 | 411,634 | 0 | |
Dec 06 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Option Exercise | D | 26.64 | 16,000 | 426,240 | 0 | |
Dec 06 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Option Exercise | D | 27.27 | 30,000 | 818,100 | 0 | |
Dec 06 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Option Exercise | D | 20.45 | 11,041 | 225,788 | 0 | |
Dec 06 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Option Exercise | D | 19.94 | 3,753 | 74,835 | 0 | |
Dec 06 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Sell | D | 33.25 | 45 | 1,496 | 0 | 45 to 0 (-100.00 %) |
Dec 06 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Buy | I | 24.98 | 20 | 500 | 45 | 25 to 45 (+80.00 %) |
Jul 06 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Buy | I | 24.16 | 24 | 580 | 24 | 0 to 24 |
May 27 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Option Exercise | M | 20.45 | 5,333 | 109,060 | 11,041 | |
May 27 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Option Exercise | M | 19.94 | 326 | 6,500 | 3,753 | |
May 27 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Option Exercise | M | 19.94 | 100 | 1,994 | 4,079 | |
May 27 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Sell | S | 28.70 | 5,659 | 162,413 | 0 | 5.7 K to 0 (-100.00 %) |
May 27 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Buy | M | 20.45 | 5,333 | 109,060 | 5,659 | 326 to 5.7 K (+1,635.89 %) |
May 27 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Buy | M | 19.94 | 326 | 6,500 | 326 | 0 to 326 |
May 27 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Sell | S | 28.70 | 100 | 2,870 | 0 | 100 to 0 (-100.00 %) |
May 27 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Buy | M | 19.94 | 100 | 1,994 | 100 | 0 to 100 |
May 23 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Option Exercise | M | 20.45 | 187 | 3,824 | 16,374 | |
May 23 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Option Exercise | M | 19.94 | 413 | 8,235 | 4,179 | |
May 23 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Sell | S | 29.01 | 600 | 17,406 | 0 | 600 to 0 (-100.00 %) |
May 23 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Buy | M | 20.45 | 187 | 3,824 | 600 | 413 to 600 (+45.28 %) |
May 23 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Buy | M | 19.94 | 413 | 8,235 | 413 | 0 to 413 |
Feb 25 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Feb 25 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Option Exercise | A | 27.27 | 30,000 | 818,100 | 30,000 |
Page: 1